Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
Quintiles to make minority investment in Samsung biosimilars’ manufacturing facility.
RESEARCH TRIANGLE PARK (NORTH CAROLINA), US: To support Samsung’s entry into the biopharmaceuticals market, Quintiles has entered into a strategic partnership with Samsung, Quintiles announced in a press release. Under an agreement signed recently, Quintiles will make a minority 10 per cent investment of approximately $ 30 million to start a new joint venture company with Samsung in the first half of 2011 to provide biopharmaceutical contract manufacturing services in South Korea. The strategic partnership will support Samsung’s entry into the biopharmaceutical market and reinforces Quintiles’ role as an ally to help companies succeed in the new health landscape.
The joint venture company represents Samsung’s first step into the biopharmaceutical business. Samsung also plans to commercialize biosimilars by 2016 and expand into innovative biologics in the future. Plans call for the joint venture company to construct a biopharmaceutical manufacturing plant in Songdo, Incheon, South Korea. Groundbreaking is expected in the first half of 2011 and full-scale operation is expected to commence in April 2013. The plant will be equipped to produce 1,300 pounds (600 kilogram) of biopharmaceutical products. The products are expected to be sold mostly in international markets.
© WOC News
Login
The MDI plant Brunsbüttel will see a rise in production capacity to 420,000 metric tons a year. The plan is to invest roughly €100 million i ...
ANAHEIM, US: SABIC innovative plastics’ recently said that GE Healthcare has selected its Valox resin for the housing and Xylex resin for the ...
$ 17 million invested in Gevo’s IPO 10-year exclusive supply agreement with Gevo Biobased butyl rubber successfully produced in tests &nb ...
TOKYO, JAPAN: As a part of Teijin's long-term growth strategy, the company will integrate its business units for carbon fibers and composite materia ...
HELSINKI, FINLAND: Following seven years as President and CEO of Dynea group, Roger Carlstedt will retire on February 28, 2011. After Carlstedt&rsqu ...
The company is significantly expanding its polyether ether ketone (PEEK) capacity in response to growing global demand. Along with a number of optim ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder